Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 22, 2005
Occupational sensitization to ribosome-inactivating proteins in researchersK Szalai, I Schöll, E Förster-Waldl, et al.British Journal of Haematology|June 1, 1992
Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluationP L Tazzari, A Bolognesi, D de Totero, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative GroupG Bonadonna, M Zambetti, C Bumma, et al.Tumori|March 18, 1999
Quality control by portal film analysis in radiotherapy for prostate cancer: a comparison between two different institutions and treatment techniquesC Italia, C Fiorino, M Ciocca, et al.Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasiaA Bolognesi, L Polito, V Farini, et al.Biochimica Et Biophysica Acta|October 19, 1993
Purification and partial characterization of single-chain ribosome-inactivating proteins from the seeds of Phytolacca dioica LA Parente, P De Luca, A Bolognesi, et al.Health Physics|November 30, 2012
Evaluation of second cancer induction risk by CT follow-up in oncological long-surviving patientsR Calandrino, V Ardu, D Corletto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.itF Boccardo, A Rubagotti, D Amoroso, et al.Planta|April 23, 1999
Isolation and characterization of four type-1 ribosome-inactivating proteins, with polynucleotide:adenosine glycosidase activity, from leaves of Phytolacca dioica LA Di Maro, P Valbonesi, A Bolognesi, et al.British Journal of Cancer|June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyE Baldini, T Prochilo, B Salvadori, et al.Pageof 9